PharmaCielo (TSE:PCLO) has released an update.
PharmaCielo, a leader in medicinal-grade cannabis cultivation and production, has announced that trading of its securities on the TSX Venture Exchange is expected to resume shortly following a revocation of a cease trade order by the OSC. The company has also successfully closed the final tranche of a non-brokered private placement, signaling progress in its efficiency program and financial initiatives.
For further insights into TSE:PCLO stock, check out TipRanks’ Stock Analysis page.
